Walleye Trading
CLVS

Walleye Trading’s Clovis Oncology, Inc. CLVS Stock Holding History

Walleye Trading’s Portfolio CLVS Stock Details CLVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-29,731
Closed -$58.4K – 6141
2021
Q4 		$81K Buy
29,731
+26,812
+919% +$99.1K ﹤0.01% 4491
2021
Q3 		$13K Buy
+2,919
New +$14.1K ﹤0.01% 4966
2021
Q2 		– Sell
-25,507
Closed -$149K – 5682
2021
Q1 		$179K Buy
25,507
+6,443
+34% +$43.2K ﹤0.01% 3732
2020
Q4 		$92K Buy
19,064
+12,503
+191% +$63.2K ﹤0.01% 3973
2020
Q3 		$38K Buy
+6,561
New +$39.3K ﹤0.01% 3715
2020
Q1 		– Sell
-6,636
Closed -$53.2K – 4760
2019
Q4 		$69K Sell
6,636
-27,710
-81% -$201K ﹤0.01% 3714
2019
Q3 		$135K Sell
34,346
-10,809
-24% -$87.4K ﹤0.01% 3183
2019
Q2 		$671K Buy
45,155
+44,222
+4,740% +$799K 0.01% 1947
2019
Q1 		$23K Buy
+933
New +$23.4K ﹤0.01% 3882
2015
Q4 		– Sell
-508
Closed -$47K – 5847
2015
Q3 		$47K Buy
+508
New +$44K ﹤0.01% 3552

Other funds holding CLVS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
QF
QVT Financial New York $1.37B AUM 148.1% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
E
Ergoteles New York $68.2M AUM 36.16% 1-Year Est. Return
PA
Pinnacle Associates New York $7.78B AUM 45.07% 1-Year Est. Return

Walleye Trading's CLVS Position: Q1 2022 in Review

Walleye Trading sold out of Clovis Oncology, Inc. (CLVS) in Q1 2022, closing a stake of 29,731 shares — an estimated $58.4K sold.

Walleye Trading first reported a position in CLVS in Q3 2015 and held it in 10 quarters. The position peaked at $671K in Q2 2019. 153 funds tracked by Wall St. Rank hold CLVS as of Q1 2022.

  • Walleye Trading reported no remaining Clovis Oncology, Inc. position as of Q1 2022 after selling out during the quarter.
  • Walleye Trading sold 29,731 Clovis Oncology, Inc. shares in Q1 2022, an estimated $58.4K.
  • Walleye Trading first reported a position in Clovis Oncology, Inc. in Q3 2015 and held it in 10 quarters.
  • Walleye Trading's Clovis Oncology, Inc. position peaked at $671K in Q2 2019.
  • 153 funds tracked by Wall St. Rank held Clovis Oncology, Inc. as of Q1 2022.

Based on Walleye Trading's 13F filing for Q1 2022, filed 16 May 2022.